{
    "clinical_study": {
        "@rank": "78783", 
        "arm_group": [
            {
                "arm_group_label": "Starter infant formula without HMO", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Volumes of feed depend on age, weight and appetite."
            }, 
            {
                "arm_group_label": "Starter infant formula with 2 HMOs", 
                "arm_group_type": "Active Comparator", 
                "description": "Volumes of feeds depend on age, weight and appetite"
            }, 
            {
                "arm_group_label": "Breasfed reference group", 
                "arm_group_type": "No Intervention"
            }
        ], 
        "brief_summary": {
            "textblock": "The primary objective of this clinical study is to show that infants fed a standard starter\n      infant formula with 2 Human Milk Oligosaccharides (HMOs) have a growth in line with infants\n      fed a standard starter infant formula without HMOs."
        }, 
        "brief_title": "Clinical Safety of a New Infant Starter Formula Containing 2 Human Milk Oligosaccharides (HMOs)", 
        "completion_date": {
            "#text": "April 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Healthy", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Healthy babies\n\n          -  Full term babies (37 weeks \u2264 gestation \u2264 42 weeks)\n\n          -  birth weight between 2500 g- 4500g\n\n          -  Having obtained the baby's legal representative's informed consent.\n\n          -  FF groups:\n\n        babies aged between birth and 14 days, exclusively formula-fed at time of enrollment,\n        whose mother independently elected, before enrollment, not to breastfeed\n\n        \u2022 BF group: babies aged 3 months (+/- 5 days), exclusively breastfed since birth.\n\n        Exclusion Criteria:\n\n          -  Congenital illness or malformation that may affect growth\n\n          -  Significant pre-natal and/or serious post-natal disease before enrollment (by medical\n             decision)\n\n          -  Minor parent(s)\n\n          -  Newborn whose parents / caregivers cannot be expected to comply with study procedures\n\n          -  Currently participating or having participated in another clinical trial since birth,\n             except for BF group, where vaccines studies are allowed."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "14 Days", 
            "minimum_age": "N/A"
        }, 
        "enrollment": {
            "#text": "176", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 24, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01715246", 
            "org_study_id": "11.26.INF"
        }, 
        "intervention": {
            "arm_group_label": [
                "Starter infant formula without HMO", 
                "Starter infant formula with 2 HMOs"
            ], 
            "intervention_name": "Infant Formula", 
            "intervention_type": "Other"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "healthy babbies", 
            "infant formula", 
            "growth", 
            "HMO"
        ], 
        "lastchanged_date": "November 22, 2013", 
        "location": [
            {
                "contact": {
                    "email": "philippe.alliet@jessazh.be", 
                    "last_name": "ALLIET", 
                    "phone": "+ 32 11 30 98 65"
                }, 
                "facility": {
                    "address": {
                        "city": "Hasselt", 
                        "country": "Belgium", 
                        "zip": "3500"
                    }, 
                    "name": "Kinderartsenpraktijk"
                }, 
                "investigator": {
                    "last_name": "ALLIET", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "CORSELLO"
                }, 
                "facility": {
                    "address": {
                        "city": "Palermo", 
                        "country": "Italy", 
                        "zip": "90127"
                    }, 
                    "name": "Dipartimento Materno Infantile"
                }, 
                "investigator": {
                    "last_name": "CORSELLO", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": [
                "Belgium", 
                "Italy"
            ]
        }, 
        "number_of_arms": "3", 
        "official_title": "Clinical Safety of a New Infant Starter Formula Containing 2 Human Milk Oligosaccharides (HMOs)", 
        "overall_official": [
            {
                "affiliation": "Dipartimento Materno Infantile, Palermo", 
                "last_name": "Giovanni CORSELLO", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Kinderartsenpraktijk, Hasselt, Belgium", 
                "last_name": "Philippe ALLIET", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "Belgium: Ethics Committee", 
                "Italy: Ethics Committee"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "November 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "child growth (body weight) from enrollment to 4 months of age", 
            "measure": "Growth", 
            "safety_issue": "No", 
            "time_frame": "4 months of life"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01715246"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Growth", 
                "safety_issue": "No", 
                "time_frame": "6 and 12 months of age"
            }, 
            {
                "description": "Parents are asked to complete a diary on digistive tolerance of their child", 
                "measure": "Digestive tolerance (stool charecteristics, bowel movements,behavior patterns)", 
                "safety_issue": "No", 
                "time_frame": "every month during 6 months"
            }, 
            {
                "description": "Parents are asked to complete a diary on the product compliance", 
                "measure": "Product compliance (quantity of formula in ml consumed on the 3 days before visit)", 
                "safety_issue": "No", 
                "time_frame": "every month for 6 months"
            }, 
            {
                "measure": "Morbidity", 
                "safety_issue": "No", 
                "time_frame": "ongoing for 1 year"
            }, 
            {
                "measure": "Stool microbiota", 
                "safety_issue": "No", 
                "time_frame": "3 and 12 months of age"
            }, 
            {
                "measure": "Gene expression", 
                "safety_issue": "No", 
                "time_frame": "3 and 12 months of age"
            }
        ], 
        "source": "Nestl\u00e9", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Nestl\u00e9", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "October 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Caregiver), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "November 2013"
    }
}